Decision Algorithms for the Retreatment with Viscosupplementation in Patients Suffering from Knee Osteoarthritis: Recommendations from the EUROpean VIScosupplementation COnsensus Group (EUROVISCO)
Henrotin, Yves ; Université de Liège > Département des sciences de la motricité > Unité de recherche sur l'os et le cartilage (U.R.O.C.)
Chevalier, Xavier
Migliore, Alberto
Jerosch, Jorg
Montfort, Jordi
Bard, Herve
Baron, Dominique
Richette, Pascal
Conrozier, Thierry
Language :
English
Title :
Decision Algorithms for the Retreatment with Viscosupplementation in Patients Suffering from Knee Osteoarthritis: Recommendations from the EUROpean VIScosupplementation COnsensus Group (EUROVISCO)
Jordan KM, Arden NK, Doherty M, Bannwarth B, Bijlsma JW, Dieppe P,; Standing Committee for International Clinical Studies Including Therapeutic Trials ESCISIT. EULAR recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis. 2003;62:1145-55
Hochberg MC, Altman RD, April KT, Benkhalti M, Guyatt G, McGowan; American College of Rheumatology. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res. 2012;64:465-74
McAlindon TE, Bannuru RR, Sullivan MC, Arden NK, Berenbaum F, Bierma-Zeinstra S. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis Cartilage. 2014;22:363-88
Bruyère Cooper C, Pelletier JP, Branco J, Luisa Brandi M, Guillemin F. An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: a report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Semin Arthritis Rheum. 2014;44:253-63. doi:10.1016/j.semarthrit.2014.05.014
Balazs EA, Denlinger JL. Viscosupplementation: a new concept in the treatment of osteoarthritis. J Rheumatol. 1993;39(Suppl):3-9
Balazs EA. Viscosupplementation for treatment of osteoarthritis: from initial discovery to current status and results. Surg Technol Int. 2004;12:278-89
Maheu E, Rannou F, Reginster JY. Efficacy and safety of hyaluronic acid in the management of osteoarthritis: evidence from real-life setting trials and surveys. Semin Arthritis Rheum. 2016;45(4 Suppl):S28-33. doi:10.1016/j.semarthrit.2015.11.008
Abdulla A, Adams N, Bone M, Elliott AM, Gaffin J, Jones D,; British Geriatric Society. Guidance on the management of pain in older people. Age Ageing. 2013;42(Suppl 1):i1-57. doi:10.1093/ageing/afs200
Bruyère O, Cooper C, Pelletier JP, Maheu E, Rannou F, Branco J. A consensus statement on the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) algorithm for the management of knee osteoarthritis—from evidence-based medicine to the real-life setting. Semin Arthritis Rheum. 2016;45(4 Suppl):S3-11. doi:10.1016/j.semarthrit.2015.11.010
Bannuru RR, Schmid CH, Kent DM, Vaysbrot EE, Wong JB, McAlindon TE. Comparative effectiveness of pharmacologic interventions for knee osteoarthritis: a systematic review and network meta-analysis. Ann Intern Med. 2015;162:46-54. doi:10.7326/M14-1231
Campbell KA, Erickson BJ, Saltzman BM, Mascarenhas R, Bach BR, Jr Cole BJ. Is local viscosupplementation injection clinically superior to other therapies in the treatment of osteoarthritis of the knee: a systematic review of overlapping meta-analyses. Arthroscopy. 2015;31:2036-45.e14. doi:10.1016/j.arthro.2015.03.030
Posnett J, Dixit S, Oppenheimer B, Kili S, Mehin N. Patient preference and willingness to pay for knee osteoarthritis treatments. Patient Prefer Adherence. 2015;9:733-44. doi:10.2147/PPA.S84251
Campbell J, Bellamy N, Gee T. Differences between systematic reviews/meta-analyses of hyaluronic acid/hyaluronan/hylan in osteoarthritis of the knee. Osteoarthritis Cartilage. 2007;15:1424-36
Jevsevar D, Donnelly P, Brown GA, Cummins DS. Viscosupplementation for osteoarthritis of the knee: a systematic review of the evidence. J Bone Joint Surg Am. 2015;97:2047-60. doi:10.2106/JBJS.N.00743
Herrero-Beaumont G, Guerrero R, Sánchez-Pernaute O, Acebes C, Palacios I, Mas S. Cartilage and bone biological markers in the synovial fluid of osteoarthritic patients after hyaluronan injections in the knee. Clin Chim Acta. 2001;308:107-15
Conrozier T, Balblanc JC, Richette P, Mulleman D, Maillet B, Henrotin Y. Early effect of hyaluronic acid intra-articular injections on serum and urine biomarkers in patients with knee osteoarthritis: an open-label observational prospective study. J Orthop Res. 2012;30:679-85. doi:10.1002/jor.21580
Henrotin Y, Chevalier X, Deberg M, Balblanc JC, Richette P, Mulleman D. Early decrease of serum biomarkers of type II collagen degradation (Coll2-1) and joint inflammation (Coll2-1 NO2) by hyaluronic acid intra-articular injections in patients with knee osteoarthritis: a research study part of the Biovisco study. J Orthop Res. 2013;31:901-7. doi:10.1002/jor.22297
Henrotin Y, Raman R, Richette P, Bard H, Jerosch J, Conrozier T. Consensus statement on viscosupplementation with hyaluronic acid for the management of osteoarthritis. Semin Arthritis Rheum. 2015;45:140-9. doi:10.1016/j.semarthrit.2015.04.011
Bannuru RR, Natov NS, Obadan IE, Price LL, Schmid CH, McAlindon TE. Therapeutic trajectory of hyaluronic acid versus corticosteroids in the treatment of knee osteoarthritis: a systematic review and meta-analysis. Arthritis Rheum. 2009;61:1704-11. doi:10.1002/art
Raman R, Dutta A, Day N, Sharma HK, Shaw CJ, Johnson GV. Efficacy of Hylan G-F 20 and sodium hyaluronate in the treatment of osteoarthritis of the knee—a prospective randomized clinical trial. Knee. 2008;15:318-24. doi:10.1016/j.knee.2008.02.012
Navarro-Sarabia F, Coronel P, Collantes E, Navarro FJ, de la, Serna AR, Naranjo A,; Amelia Study Group. A 40-month multicentre, randomised placebo-controlled study to assess the efficacy and carry-over effect of repeated intra-articular injections of hyaluronic acid in knee osteoarthritis: the AMELIA project. Ann Rheum Dis. 2011;70:1957-62. doi:10.1136/ard.2011.152017
Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol. 1988;15:1833-40
Tubach F, Ravaud P, Martin-Mola E, Awada H, Bellamy N, Bombardier C. Minimum clinically important improvement and patient acceptable symptom state in pain and function in rheumatoid arthritis, ankylosing spondylitis, chronic back pain, hand osteoarthritis, and hip and knee osteoarthritis: results from a prospective multinational study. Arthritis Care Res. 2012;64:1699-707. doi:10.1002/acr.21747
Roos EM, Roos HP, Lohmander LS, Ekdahl C, Beynnon BD. Knee Injury and Osteoarthritis Outcome Score (KOOS)—development of a self-administered outcome measure. J Orthop Sports Phys Ther. 1998;28:88-96
Pham T, van der Heijde D, Altman RD, Anderson JJ, Bellamy N, Hochberg M. OMERACT-OARSI initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited. Osteoarthritis Cartilage. 2004;12:389-99
Kellgren JH, Lawrence JS. Radiological assessment of osteoarthrosis. Ann Rheum Dis. 1957;16:494-501
Marty M, Hilliquin P, Rozenberg S, Valat JP, Vignon E, Coste P. Validation of the KOFUS (Knee Osteoarthritis Flare-Ups Score). Joint Bone Spine. 2009;76:268-72. doi:10.1016/j.jbspin.2008.07.018
Bellamy N, Hochberg M, Tubach F, Martin-Mola E, Awada H, Bombardier C. Development of multinational definitions of minimum clinically important improvement and patient acceptable symptom state in osteoarthritis. Arthritis Care Res (Hoboken). 2015;67:972-80
Pagnano M, Westrich G. Successful nonoperative management of chronic osteoarthritis pain of the knee: safety and efficacy of retreatment with intra-articular hyaluronans. Osteoarthritis Cartilage. 2005;13:751-61
Altman RD, Rosen JE, Bloch DA, Hatoum HT. Safety and efficacy of retreatment with a bioengineered hyaluronate for painful osteoarthritis of the knee: results of the open-label Extension Study of the FLEXX Trial. Osteoarthritis Cartilage. 2011;19:1169-75. doi:10.1016/j.joca.2011.07.001
Strand V, Lim S, Takamura J. Evidence for safety of retreatment with a single intra-articular injection of Gel-200 for treatment of osteoarthritis of the knee from the double-blind pivotal and open-label retreatment clinical trials. BMC Musculoskelet Disord. 2016;17:240. doi:10.1186/s12891-016-1101-0
Waddell DD, Bricker DC. Hylan G-F 20 tolerability with repeat treatment in a large orthopedic practice: a retrospective review. J Surg Orthop Adv. 2006;15:53-9
Parkes MJ, Callaghan MJ, O’Neill TW, Forsythe LM, Lunt M, Felson DT. Sensitivity to change of patient-preference measures for pain in trials of patients with knee osteoarthritis: a secondary analysis from the BRACE and TASK trials. Arthritis Care Res (Hoboken). 2016;68:1224-31. doi:10.1002/acr.22823
Roubille C, Raynauld JP, Abram F, Paiement P, Dorais M, Delorme P. The presence of meniscal lesions is a strong predictor of neuropathic pain in symptomatic knee osteoarthritis: a cross-sectional pilot study. Arthritis Res Ther. 2014;16:507. doi:10.1186/s13075-014-0507-z
Havelin J, Imbert I, Cormier J, Allen J, Porreca F, King T. Central sensitization and neuropathic features of ongoing pain in a rat model of advanced osteoarthritis. J Pain. 2016;17:374-82. doi:10.1016/j.jpain.2015.12.001
Altman RD, Manjoo A, Fierlinger A, Niazi F, Nicholls M. The mechanism of action for hyaluronic acid treatment in the osteoarthritic knee: a systematic review. BMC Musculoskelet Disord. 2015;16:321. doi:10.1186/s12891-015-0775
Eymard F, Chevalier X, Conrozier T. Obesity and severity of joint space narrowing are associated with a lower rate of success of viscosupplementation in patients with knee osteoarthritis. Post-hoc analysis of a double-blind, controlled, multicenter, randomized trial. Osteoarthritis Cartilage. 2016;24:S528
Clarke S, Lock V, Duddy J, Sharif M, Newman JH, Kirwan JR. Intra-articular Hylan G-F 20 (Synvisc) in the management of patellofemoral osteoarthritis of the knee (POAK). Knee. 2005;12:57-62
Conrozier T, Mathieu P, Schott AM, Laurent I, Hajri T, Crozes P. Factors predicting long-term efficacy of Hylan GF-20 viscosupplementation in knee osteoarthritis. Joint Bone Spine. 2003;70:128-33
Zóboli AA, de Rezende MU, de Campos GC, Pasqualin T, Frucchi R, de Camargo OP. Prospective randomized clinical trial: single and weekly viscosupplementation. Acta Ortop Bras. 2013;21:271-5. doi:10.1590/S1413-78522013000500006
Douglas RJ. Aspiration and injection of the knee joint: approach portal. Knee Surg Relat Res. 2014;26:1-6. doi:10.5792/ksrr.2014.26.1
Cardone DA, Tallia AF. Diagnostic and therapeutic injection of the hip and knee. Am Fam Physician. 2003;67:2147-52
Telikicherla M, Kamath SU. Accuracy of needle placement into the intra-articular space of the knee in osteoarthritis patients for viscosupplementation. J Clin Diagn Res. 2016;10:RC15-7. doi:10.7860/JCDR/2016/17127.7275
Paradowski PT, Lohmander LS, Englund M. Osteoarthritis of the knee after meniscal resection: long term radiographic evaluation of disease progression. Osteoarthritis Cartilage. 2016;24:794-800. doi:10.1016/j.joca.2015.12.002
Martel-Pelletier J, Raynauld JP, Dorais M, Abram F, Pelletier JP. The levels of the adipokines adipsin and leptin are associated with knee osteoarthritis progression as assessed by MRI and incidence of total knee replacement in symptomatic osteoarthritis patients: a post hoc analysis. Rheumatology (Oxford). 2016;55:680-8. doi:10.1093/rheumatology/kev408
Simon D, Mascarenhas R, Saltzman BM, Rollins M, Bach BR, Jr MacDonald P. The relationship between anterior cruciate ligament injury and osteoarthritis of the knee. Adv Orthop. 2015;2015:928301. doi:10.1155/2015/928301
Williams MF, London DA, Husni EM, Navaneethan S, Kashyap SR. Type 2 diabetes and osteoarthritis: a systematic review and meta-analysis. J Diabetes Complications. 2016;30:944-50. doi:10.1016/j.jdiacomp.2016.02.016
Musumeci G, Aiello FC, Szychlinska MA, Di Rosa M, Castrogiovanni P, Mobasheri A. Osteoarthritis in the XXIst century: risk factors and behaviours that influence disease onset and progression. Int J Mol Sci. 2015;16:6093-112. doi:10.3390/ijms16036093
Wang CT, Lin YT, Chiang BL, Lin YH, Hou SM. High molecular weight hyaluronic acid down-regulates the gene expression of osteoarthritis-associated cytokines and enzymes in fibroblast-like synoviocytes from patients with early osteoarthritis. Osteoarthritis Cartilage. 2006;14:1237-47
Li P, Raitcheva D, Hawes M, Moran N, Yu X, Wang F. Hylan G-F 20 maintains cartilage integrity and decreases osteophyte formation in osteoarthritis through both anabolic and anti-catabolic mechanisms. Osteoarthritis Cartilage. 2012;20:1336-46
Li J, Gorski DJ, Anemaet W, Velasco J, Takeuchi J, Sandy JD. Hyaluronan injection in murine osteoarthritis prevents TGFbeta 1-induced synovial neovascularization and fibrosis and maintains articular cartilage integrity by a CD44-dependent mechanism. Arthritis Res Ther. 2012;14:R151. doi:10.1186/ar38871
Wang Y, Hall S, Hanna F, Wluka AE, Grant G, Marks P. Effects of Hylan G-F 20 supplementation on cartilage preservation detected by magnetic resonance imaging in osteoarthritis of the knee: a two-year single-blind clinical trial. BMC Musculoskelet Disord. 2011;12:195. doi:10.1186/1471-2474-12-195
Yanagisawa K, Muneta T, Ozeki N, Nakagawa Y, Udo M, Saito R. Weekly injections of Hylan G-F 20 delay cartilage degeneration in partial meniscectomized rat knees. BMC Musculoskelet Disord. 2016;17:188. doi:10.1186/s12891-016-1051-6
Liu CC, Su LJ, Tsai WY, Sun HL, Lee HC, Wong CS. Hylan G-F 20 attenuates posttraumatic osteoarthritis progression: association with upregulated expression of the circadian gene NPAS2. Life Sci. 2015;141:20-4. doi:10.1016/j.lfs.2015.09.007
Altman R, Lim S, Steen RG, Dasa V. Hyaluronic acid injections are associated with delay of total knee replacement surgery in patients with knee osteoarthritis: evidence from a large U.S. health claims database. PLoS One. 2015;10:e0145776
Yu CJ, Ko CJ, Hsieh CH, Chien CT, Huang LH, Lee CW. Proteomic analysis of osteoarthritic chondrocyte reveals the hyaluronic acid–regulated proteins involved in chondroprotective effect under oxidative stress. J Proteomics. 2014;99:40-53. doi:10.1016/j.jprot.2014.01.016
